The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Hologic Inc

Nasdaq: HOLX
Last

(U.S.) $39.76

Today's change+0.45 +1.14%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Hologic Inc

Nasdaq: HOLX
Last

(U.S.) $39.76

Today's change+0.45 +1.14%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.

Hologic Inc up (U.S.)$0.45

Hologic Inc closed up Friday by (U.S.)$0.45 or 1.14% to (U.S.)$39.76. Over the last five days, shares are unchanged, but have gained 48.69% over the last year to date. This security has outperformed the S&P 500 by 60.27% during the last year.

Key company metrics

  • Open(U.S.) $39.24
  • Previous close(U.S.) $39.31
  • High(U.S.) $39.78
  • Low(U.S.) $38.52
  • Bid / Ask-- / --
  • YTD % change+48.69%
  • Volume2,210,599
  • Average volume (10-day)3,112,231
  • Average volume (1-month)4,433,316
  • Average volume (3-month)3,115,339
  • 52-week range(U.S.) $22.70 to (U.S.) $43.00
  • Beta1.24
  • Trailing P/E85.37×
  • P/E 1 year forward23.91×
  • Forward PEG2.81×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $0.47
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+5.05%

Based on its net profit margin of 5.05%, Hologic Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.71%Sector:HealthcareIndustry:Advanced Medical Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 27, 201506/27/2015Mar 28, 201503/28/2015Dec 27, 201412/27/2014Sep 27, 201409/27/2014
Revenue694656653661
Total other revenue--------
Total revenue694656653661
Gross profit379336339345
Total cost of revenue315320314316
Total operating expense596546556569
Selling / general / administrative167143147152
Research & development56535252
Depreciation / amortization27282829
Interest expense (income), net operating--------
Unusual expense (income)3021520
Other operating expenses, total------0
Operating income981109792
Interest income (expense), net non-operating-52-49-53-53
Gain (loss) on sale of assets--------
Other--------
Income before tax47614439
Income after tax29482928
Income tax, total17131511
Net income29482928
Total adjustments to net income--------
Net income before extra. items29482928
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items29482928
Inc. avail. to common incl. extra. items29482928
Diluted net income29482928
Dilution adjustment------0
Diluted weighted average shares293288283282
Diluted EPS excluding extraordinary itemsvalue per share0.100.170.100.10
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.170.170.140.04